Related Experiment Video

Updated: Jul 14, 2026

Differentiation of Human Pluripotent Stem Cells into Insulin-Producing Islet Clusters
08:41

Differentiation of Human Pluripotent Stem Cells into Insulin-Producing Islet Clusters

Published on: June 23, 2023

Stem/Progenitor cell sources of insulin-producing cells for the treatment of diabetes

Lye T Lock1, Emmanuel S Tzanakakis

  • 1Department of Chemical and Biological Engineering, State University of New York at Buffalo, Buffalo, New York 14260, USA.

Tissue Engineering
|June 7, 2007
PubMed

Insights

Diabetes treatment via islet transplantation is limited by donor scarcity. Researchers are exploring stem cells and progenitor cells to generate insulin-producing cells, aiming to overcome this challenge for diabetes reversal.

Area of Science:

  • Regenerative Medicine
  • Endocrinology
  • Stem Cell Biology

Background:

  • Diabetes mellitus is characterized by reduced insulin secretion due to a loss of pancreatic islet cells.
  • Islet transplantation offers a potential cure for diabetes, but is severely limited by the shortage of donor islets.

Purpose of the Study:

  • To review current strategies for generating insulin-producing cells from various sources.
  • To discuss the potential of embryonic stem cells and adult progenitor cells for beta-cell replacement therapy.
  • To highlight challenges hindering the clinical application of these novel cell sources.

Main Methods:

  • Review of scientific literature on stem cell differentiation and progenitor cell expansion for beta-cell generation.
  • Analysis of studies focusing on in vivo and ex vivo beta-cell regeneration.
  • Discussion of the characteristics of generated insulin-producing cells compared to native beta-cells.

Main Results:

  • Embryonic stem cells and adult progenitor cells show promise as sources for generating insulin-producing cells.
  • Current methods yield cells with partial beta-cell functions, necessitating further refinement.
  • Pharmacological strategies for stimulating beta-cell regeneration are also being investigated.

Conclusions:

  • Generating functional beta-cells from stem or progenitor cells is a key area of research for diabetes therapy.
  • Significant challenges remain in achieving complete functional maturity and ensuring clinical safety.
  • Continued research is crucial to overcome limitations and advance islet cell replacement strategies.

More Related Videos

Optimized Protocol for Generating Functional Pancreatic Insulin-secreting Cells from Human Pluripotent Stem Cells06:33

Optimized Protocol for Generating Functional Pancreatic Insulin-secreting Cells from Human Pluripotent Stem Cells

Published on: February 2, 2024

Differentiation of Human Pluripotent Stem Cells Into Pancreatic Beta-Cell Precursors in a 2D Culture System10:12

Differentiation of Human Pluripotent Stem Cells Into Pancreatic Beta-Cell Precursors in a 2D Culture System

Published on: December 16, 2021

Related Concept Videos

iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Tissue Renewal without Stem Cells01:23

Tissue Renewal without Stem Cells

After cellular or tissue damage, the resident stem cells present in the human body can locally repair and regenerate the damaged tissue or organ. However, even though some tissues do not have stem cells, they can repair and regenerate with the help of pre-existing cells. For example, beta cells of the pancreas and hepatocytes of the liver can divide to renew and regenerate the tissue. Here, both cell division and cell death are well regulated by homeostasis.
However, failure of such a system...
Stem Cell Culture01:17

Stem Cell Culture

Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
Insulin: Biosynthesis, Chemistry, and Preparation01:25

Insulin: Biosynthesis, Chemistry, and Preparation

The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment primarily uses...